相似文献/References:
[1]牛树茂,徐元贞,赵殿有,等.肝动脉灌注化疗后引起带状疱疹样皮疹六例报告[J].介入放射学杂志,1994,(01):54.
[2]董永华,袁弥满,林贵,等.原发性肝癌患者介入治疗期间的NK活性变化[J].介入放射学杂志,1994,(04):197.
[3]秦伟,巫北海.5-FUDR经肝动脉灌注致硬化性胆管炎[J].介入放射学杂志,1996,(01):59.
[4]范新东,朱凌,董敏俊,等.双路动脉化疗治疗头颈部鳞状细胞癌[J].介入放射学杂志,2006,(06):339.
FAN Xin-dong,ZHU Ling,DONG Ming-jun,et al."Double route arterial chemotherapy " in treatment for head and neck cancer[J].journal interventional radiology,2006,(01):339.
[5]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors：a therapeutic analysis[J].journal interventional radiology,2010,(01):442.
[6]中国抗癌协会肿瘤介入学专业委员会,中国抗癌协会肿瘤介入学专业委员会化疗与免疫治疗分委会.改良式经皮肝动脉化疗药盒植入技术中国专家共识（2022版）[J].介入放射学杂志,2022,31(07):633.
Professional Committee of Oncology Intervention,China Anti-Cancer Association,Chinese expert consensus on the modified implantation technique of port-catheter system for percutaneous hepatic arterial infusion chemotherapy（version 2022）[J].journal interventional radiology,2022,31(01):633.
[7]徐永康,付舒敏,李 丹,等.肝动脉灌注化疗联合系统治疗在原发性肝癌中的研究进展[J].介入放射学杂志,2023,32(01):94.
XU Yongkang,FU Shumin,LI Dan,et al.Research progress in hepatic arterial infusion chemotherapy combined with systemic therapy for the treatment of primary hepatocellular carcinoma[J].journal interventional radiology,2023,32(01):94.
[8]曹佳伟,李慧婷,徐玲玲,等.晚期肝癌患者行HAIC术后股动脉并发假性动脉瘤致骨筋膜室综合征的护理1例[J].介入放射学杂志,2024,33(04):459.
CAO Jiawei,LI Huiting,XU Lingling,et al.Nursing care for osteofascial compartment syndrome caused by iatrogenic pseudoaneurysm in one patient with advanced liver cancer after receiving hepatic artery infusion chemotherapy[J].journal interventional radiology,2024,33(01):459.
[9]张岩基,王汇源,李浩,等.经导管动脉化疗栓塞和肝动脉灌注化疗治疗肝细胞癌现状和进展[J].介入放射学杂志,2024,33(09):1039.
ZHANG Yanji,WANG Huiyuan,LI Hao,et al.Current status and progress of TACE and HAIC in the treatment of hepatocellular carcinoma[J].journal interventional radiology,2024,33(01):1039.
[10]殷梦杰,付守忠,戴锋,等.肝动脉灌注化疗联合卡瑞利珠单抗及索拉非尼治疗中晚期肝癌的疗效与安全性分析 [J].介入放射学杂志,2024,33(11):1212.
YIN Mengjie,FU Shouzhong,DAI Feng,et al.Hepatic arterial infusion chemotherapy combined with carrelizumab and sorafenib for the treatment of advanced hepatocellular carcinoma：its clinical efficacy and safety[J].journal interventional radiology,2024,33(01):1212.